Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint

Since COVID-19 has emerged as a word public health problem, attention has been focused on how immune-suppressive drugs used for the treatment of autoimmune disorders influence the risk for SARS-CoV-2 infection and the development of acute respiratory distress syndrome (ARDS). Here, we discuss the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Alborghetti, Marika, Bellucci, Gianmarco, Gentile, Antonietta, Calderoni, Chiara, Nicoletti, Ferdinando, Capra, Ruggero, Salvetti, Marco, Centonze, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199540/
https://www.ncbi.nlm.nih.gov/pubmed/33784961
http://dx.doi.org/10.2174/1570159X19666210330094017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199540/
https://www.ncbi.nlm.nih.gov/pubmed/33784961
http://dx.doi.org/10.2174/1570159X19666210330094017

Ejemplares similares